{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:25:19Z","timestamp":1793057119838,"version":"4.5.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Data regarding the prognostic significance of pleural effusion (PE) are scarce.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>Explore the impact of PE on mortality among hospitalized patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Multicenter prospective observational study. Patients that underwent computed tomography (thorax and\/or abdomen) and in which PE was detected, were admitted to the study. PE was classified by size on CT, anatomical distribution, diagnosis, and Light's criteria. Charlson comorbidity index (CCI), APACHE II, and SOFA score were calculated. Mortality at 1 month and 1 year were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Five hundred and eight subjects, mean age 78 years. Overall mortality was 22.6% at 1 month and 49.4% at 1 year. Bilateral effusions were associated with higher mortality than unilateral effusions at 1 month (32 vs. 13.3%, <jats:italic>p<\/jats:italic> = 0.005) and large effusions with higher mortality than small effusions at 1 year (66.6 vs. 43.3%, <jats:italic>p<\/jats:italic> &amp;lt; 0.01). On multivariate analysis age, CCI, APACHE II, SOFA score, and bilateral distribution were associated with short-term mortality, while long-term significant predictors were CCI, APACHE II, SOFA, and malignant etiology. Exudates (excluding MPE) exhibited a survival benefit at both 1 month and 1 year but due to the smaller sample, fluid characteristics were not included in the multivariate analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Pleural effusion is a marker of advanced disease. Mortality is higher within the first month in patients with PEs related to organ failure, while patients with MPE have the worst long-term outcome. Independent predictors of mortality, apart from CCI, APACHE II, and SOFA scores, are age and bilateral distribution in the short-term, and malignancy in the long-term.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.828783","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:18:32Z","timestamp":1645683512000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Mortality Among Hospitalized Patients With Pleural Effusions. A Multicenter, Observational, Prospective Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Eleftherios","family":"Markatis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garifallia","family":"Perlepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Afthinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Pagkratis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Varsamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Chaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias C.","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I.","family":"Gourgoulianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3978\/j.issn.2072-1439.2015.04.29","article-title":"Advances and controversies in pleural diseases","volume":"7","author":"Porcel","year":"2015","journal-title":"J Thorac Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1183\/16000617.0031-2016","article-title":"Advances in pleural disease","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.12688\/f1000research.11646.1","article-title":"Diagnostic approach to pleural diseases: new tricks for an old trade","volume":"6","author":"Maldonado","year":"2017","journal-title":"F1000Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1164\/ajrccm.160.5.9903002","article-title":"Predictors of outcome and long-term survival in patients with pleural infection","volume":"160","author":"Davies","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.21101\/cejph.a3606","article-title":"Symptoms and clinical signs associated with hospital admission and mortality for heart failure","volume":"18","author":"Devroey","year":"2010","journal-title":"Cent Eur J Public Health."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax."},{"key":"B7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12890-015-0025-z","article-title":"Important prognostic factors for survival in patients with malignant pleural effusion","volume":"15","author":"Zamboni","year":"2015","journal-title":"BMC Pulm Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/resp.12658","article-title":"Predictors of prolonged stay in patients with community-acquired pneumonia and complicated parapneumonic effusion","volume":"21","author":"Kim","year":"2016","journal-title":"Respirology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4172\/2161-105X.1000184","article-title":"Mortality of hospitalized patients with pleural effusions","volume":"4","author":"Kookoolis","year":"2014","journal-title":"J Pulm Respir Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1183\/09031936.00217114","article-title":"Mortality among patients with pleural effusion undergoing thoracentesis","volume":"46","author":"DeBiasi","year":"2015","journal-title":"Eur Respir J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.chest.2016.12.014","article-title":"Nonmalignant pleural effusions: a prospective study of 356 consecutive unselected patients","volume":"151","author":"Walker","year":"2017","journal-title":"Chest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1378\/chest.12-1292","article-title":"A new, simple method for estimating pleural effusion size on CT scans","volume":"143","author":"Moy","year":"2013","journal-title":"Chest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","volume":"286","author":"Ferreira","year":"2001","journal-title":"JAMA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.mcna.2011.08.005","article-title":"Pleural effusions","volume":"95","author":"Light","year":"2011","journal-title":"Med Clin North Am."},{"key":"B17","first-page":"771","article-title":"Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure","volume":"68","author":"Davutoglu","year":"2010","journal-title":"Kardiol Pol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/clc.22239","article-title":"Prognostic role of incidental pleural effusion diagnosed during echocardiographic evaluation","volume":"37","author":"Ercan","year":"2014","journal-title":"Clin Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4103\/sjg.SJG_336_17","article-title":"The long-term outcomes of cirrhotic patients with pleural effusion","volume":"24","author":"Hung","year":"2018","journal-title":"Saudi J Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1001\/archinte.156.19.2206","article-title":"Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia?","volume":"156","author":"Hasley","year":"1996","journal-title":"Arch Intern Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/qjmed\/89.4.285","article-title":"The clinical course and management of thoracic empyema","volume":"89","author":"Ferguson","year":"1996","journal-title":"QJM."},{"key":"B24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00134-005-0064-7","article-title":"The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit","volume":"32","author":"Tu","year":"2006","journal-title":"Intensive Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/crj.12416","article-title":"Clinical characteristics and outcomes of patients with community-acquired, health-care-associated and hospital-acquired empyema","volume":"11","author":"Koma","year":"2017","journal-title":"Clin Respir J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1378\/chest.13-1558","article-title":"A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection","volume":"145","author":"Rahman","year":"2014","journal-title":"Chest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"ii4","DOI":"10.1136\/thx.2010.136978","article-title":"Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline","volume":"65","author":"Hooper","year":"2010","journal-title":"Thorax"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.828783\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:18:36Z","timestamp":1645683516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.828783\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":27,"alternative-id":["10.3389\/fmed.2022.828783"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.828783","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"828783"}}